期刊
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
卷 1808, 期 1, 页码 394-398出版社
ELSEVIER
DOI: 10.1016/j.bbamem.2010.08.021
关键词
Influenza; Channel; Channel blocker
资金
- National Institutes of Health [R21AI064797]
- Israeli Science Foundation [784/01, 1249/05, 1581/08]
- Horowitz Foundation
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064797] Funding Source: NIH RePORTER
The influenza M2 H+ channel enables the concomitant acidification of the viral lumen upon endosomic internalization. This process is critical to the viral infectivity cycle, demonstrated by the fact that M2 is one of only two targets for anti-flu agents. However, aminoadamantyls that block the M2 channel are of limited therapeutic use due to the emergence of resistance mutations in the protein. Herein, using an assay that involves expression of the protein in Escherichia coli with resultant growth retardation, we present quantitative measurements of channel blocker interactions. Comparison of detailed K-s measurements of different drugs for several influenza channels, shows that the swine flu M2 exhibits the highest resistance to aminoadamantyls of any channel known to date. From the perspective of the blocker, we show that rimantadine is consistently a better blocker of M2 than amantadine. Taken together, such detailed and quantitative analyses provide insight into the mechanism of this important and pharmaceutically relevant channel blocker system. (C) 2010 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据